Bayer — manufacturer's medicines

Bayer

Country: Germany

Bayer AG is a German group working in healthcare and agriculture. It was founded in 1863 in Barmen (now part of Wuppertal) by Friedrich Bayer and Johann Friedrich Weskott and is headquartered in Leverkusen. Its shares trade on the Frankfurt Stock Exchange and are part of the DAX index.

Bayer has three divisions: Pharmaceuticals (prescription medicines), Consumer Health (over-the-counter products) and Crop Science (crop protection and seeds). Its agriculture business grew with the acquisition of the US company Monsanto, completed in 2018.

Bayer earned its place in medical history with acetylsalicylic acid, which it launched under the Aspirin trademark in 1899. Today its pharmaceutical division focuses on cardiology and women's health, as well as oncology, haematology and ophthalmology. Its well-known medicines include Xarelto (rivaroxaban), Eylea (aflibercept), Adempas (riociguat), Nubeqa (darolutamide) and Xofigo (radium-223 dichloride).

Regorafenib (Stivarga) is an oral multikinase inhibitor developed by Bayer. The FDA approved it in 2012 for metastatic colorectal cancer, in 2013 for gastrointestinal stromal tumours after imatinib and sunitinib, and in 2017 for hepatocellular carcinoma in patients previously treated with sorafenib.

Unifarm carries Bayer's oncology medicine: Stivarga (regorafenib).

Official manufacturer website
Bayer

List of medicines by manufacturer Bayer

-5%
Stivarga
View
Bayer
40 mg 28 tablets
48723₴ 51405₴
✅ All products loaded (1)

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00